Sort
15,842 grants matching “pancreatic cancer”
New Tools for Prostate Cancer Detection and Prognostication
$538,172Sanjiv S Gambhir · Stanford University · U01 · FY2012 · CA
Interrogating the Spatial and Functional Relevance of Microbes in Pancreatic Cancer and Metastasis
$537,985Florencia McAllister · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Role of RABL6A-PP2A in neuroendocrine tumors
$537,916Dawn E Quelle · University Of Iowa · R01 · FY2021 · CA
Studies of Materials with Physiological Properties
$537,858Harvard University · R01 · FY2002 · GM
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$537,593Alan Ashworth · University Of California, San Francisco · R01 · FY2020 · CA
Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Con
$537,312Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis
$537,271Henry Shelton Earp · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis
$537,271Henry Shelton Earp · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$536,912Philip D Greenberg · University Of Washington · R01 · FY2015 · CA
Core 3: Mouse Models Core (MM Core)
$536,694Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2025 · CA
Injectable scaffolds for early detection of immune dysregulation and monitoring response to immunotherapies
$536,496Lonnie D Shea · University Of Michigan At Ann Arbor · U01 · FY2025 · EB
Identification of key tumor cell-released factors that induce cachexia
$536,401Yi-Ping Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · AR
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
$536,356Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2019 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$536,018Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$535,816Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
$535,815Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$535,638Wei R. Chen · University Of Oklahoma · R01 · FY2022 · CA
The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk
$535,542Mahdi Sheikh · International Agency For Res On Cancer · U01 · FY2025 · CA
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
$535,359Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2022 · CA
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
$535,359Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2023 · CA
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
$535,075Wendell A Lim · University Of California, San Francisco · R01 · FY2024 · CA
TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
$535,070Ashok Kumar · University Of Houston · R01 · FY2025 · AR
TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
$535,070Ashok Kumar · University Of Houston · R01 · FY2024 · AR
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
$534,914Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Engineering protein-specific proteases: targeting signaling proteins
$534,877John Orban · Univ Of Maryland, College Park · R01 · FY2021 · GM